Among 1726 pT2–pT4 urothelial carcinomas, the distribution of AR immunostaining intensity differed significantly across pT stages (p = 0.0014) and according to nodal status (p = 0.0060) as well as venous invasion (p = 0.0095). The gene discussed is AR; the disease is urothelial carcinoma.